Background: Professional societies have recommended against use of self-monitoring blood glucose (SMBG) in non-insulin-treated type 2 diabetes (NITT2D) to control blood sugar levels, but patients are still monitoring.
Objective: To understand patients' motivation to monitor their blood sugar, and whether they would stop if their physician suggested it.
Design: Cross-sectional in-person and electronic survey conducted between 2018 and 2020.